v3.26.1
Balance Sheets
Dec. 31, 2025
USD ($)
Jul. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
Current liabilities:        
Accrued expenses and other current liabilities   $ 20,000  
Non-current liability:        
TOTAL LIABILITIES   167,120   3,947
Shareholders’ equity        
Ordinary shares (par value of US$0.36 (RM1) per share; 580,000 and 580,000 shares authorized as of July 31, 2024 and 2025;    
Accumulated deficit   (167,120)   (3,947)
Total shareholders’ equity   (167,120)   (3,947)
Related Party [Member]        
Current liabilities:        
Amount due to a related party   147,120   3,947
Titan Pharmaceuticals Inc [Member]        
Current assets:        
Cash and cash equivalents $ 328,000   $ 2,831,000  
Related party receivable 3,217,000   62,000  
Prepaid expenses and other current assets 169,000   30,000  
Total current assets 3,714,000   2,923,000  
Non-current assets:        
Property and equipment, net 5,000    
Prepaid expenses – non-current 486,000    
TOTAL ASSETS 4,205,000   2,923,000  
Current liabilities:        
Accounts payable 77,000   202,000  
Notes payable 2,466,000    
Other accrued liabilities 107,000   281,000  
Total current liabilities 2,650,000   483,000  
Non-current liability:        
TOTAL LIABILITIES 2,650,000   483,000  
Commitments and contingencies (Note 4)    
Shareholders’ equity        
Preferred stock, at amounts paid-in, $0.001 par value per share; 5,000,000 shares authorized, 950,000 shares issued and outstanding at December 31, 2024   1,000  
Ordinary shares (par value of US$0.36 (RM1) per share; 580,000 and 580,000 shares authorized as of July 31, 2024 and 2025;   1,000  
Additional paid-in capital 400,576,000   398,974,000  
Accumulated deficit (399,021,000)   (396,536,000)  
Total shareholders’ equity 1,555,000   2,440,000  
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 4,205,000   2,923,000  
TALENTEC SDN. BHD. [Member]        
Current assets:        
Cash and cash equivalents   575,111   684,497
Restricted cash   608,820   549,533
Accounts receivable, net   167,153   287,324
Contract assets     3,380
Deferred costs   345,780   317,761
Deferred offering cost   710,300   369,697
Prepaid expenses and other current assets   55,731   38,914
Total current assets   2,462,895   2,251,106
Non-current assets:        
Property and equipment, net   107,965   1,365
Right-of-use asset   151,642  
Total non-current assets   259,607   1,365
TOTAL ASSETS   2,722,502   2,252,471
Current liabilities:        
Accounts payable   289,246   152,327
Notes payable   130,910   319,750
Contract liabilities   573,312   475,697
Accrued expenses and other current liabilities   603,504   182,116
Amount due to a related party     358,626
Long-term borrowings   19,597   66,193
Lease liability   63,817  
Total current liabilities   1,680,386   1,554,709
Non-current liability:        
Long-term borrowings     17,949
Lease liability   87,825  
Total non-current liability   87,825   17,949
TOTAL LIABILITIES   1,768,211   1,572,658
Shareholders’ equity        
Ordinary shares (par value of US$0.36 (RM1) per share; 580,000 and 580,000 shares authorized as of July 31, 2024 and 2025;   208,617   208,617
Additional paid-in capital   782,865   782,865
Accumulated deficit   (49,207)   (259,118)
Accumulated other comprehensive (loss) income   12,016   (52,551)
Total shareholders’ equity   954,291   679,813
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY   2,722,502   2,252,471
TALENTEC SDN. BHD. [Member] | Related Party [Member]        
Current liabilities:        
Amount due to a related party $ 358,626